|
|
| General Info |
 |
|
|
|
|
| Latest News |
- EDQM set to implement European Pharmacopoeia Version 6.8 in June 2010
European Directorate for the Quality of Medicines & HealthCare (EDQM) will
|
|
 |
|
 |
 |
  |
|
|
 |
Quality Policy |
 |
|
|
We, at MANUS AKTTEVA commit ourselves for supplying products that would give complete satisfaction to our customers.
We will strive to achieve growth and leading position in the market by:
- Supplying quality products as per our customer’s necessary and essential requirements, meeting Domestic & International standards ( complying with the requirements of Regulatory & Non-Regulatory markets ) of quality, performance and reliability.
- Complying requirements and continually improving the effectiveness of Quality Management Systems.
- Creating an environment of team work and innovative approach.
U D E E T J B A N K E R
T O P M A N A G E M E N T
1ST J A N U A R Y’ 06 |
|
|
 |
NOTE: 
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|